9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
9 hedge funds and large institutions have $182K invested in 9 Meters Biopharma in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
5% less capital invested
Capital invested by funds: $193K → $182K (-$10.4K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$11.8K |
| 2 |
ACP
Arcus Capital Partners
Atlanta,
Georgia
|
+$10.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$45.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$28K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$23.1K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DWM
1
Dynasty Wealth Management
St. Petersburg,
Florida
| $89K | +$93.6K | +730 | New |
|
|
VF
2
Virtu Financial
New York
| $24K | -$45.4K | -354 | -64% |
|
|
RPG
3
Risk Paradigm Group
Austin,
Texas
| $16.5K | – | – | – |
|
|
RJFSA
4
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $13K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $11K | -$23.1K | -180 | -66% |
|
|
TSS
6
Two Sigma Securities
New York
| $11K | +$11.8K | +92 | New |
|
|
ACP
7
Arcus Capital Partners
Atlanta,
Georgia
| $10K | +$10.4K | +81 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $8K | +$1.54K | +12 | +21% |
|
|
9
Vanguard Group
Malvern,
Pennsylvania
| – | -$28K | -197 | Closed |
|
|
10
Northern Trust
Chicago,
Illinois
| – | -$8K | -58 | Closed |
|
NMTR Hedge Fund Activity: Q4 2017 in Review
9 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q4 2017, worth a combined $182K — down 5.4% from $193K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NMTR positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $11.8K. The largest seller was Virtu Financial, cutting an estimated $45.4K.
- 9 institutional investors held 9 Meters Biopharma (NMTR) as of Q4 2017, up from 8 in Q3 2017.
- Funds reported $182K of 9 Meters Biopharma stock for Q4 2017, down 5.4% quarter-over-quarter.
- 3 funds opened new 9 Meters Biopharma positions in Q4 2017 and 2 closed out, a net change of +1 holder.
- The largest 9 Meters Biopharma buyer in Q4 2017 was Two Sigma Securities, an estimated $11.8K added.
- The largest 9 Meters Biopharma seller in Q4 2017 was Virtu Financial, an estimated $45.4K sold.
Based on aggregated 13F filings for Q4 2017.